| Issuer | % of Class | Filed |
|---|---|---|
|
Sinovac Biotech Ltd.
13D/A
Amendment 6
SVA · P8696W104
|
8.9% |
7/15/2025
Event 7/10/2025
|
|
Sinovac Biotech Ltd.
13D/A
Amendment 5
SVA · P8696W104
|
8.9% |
6/20/2025
Event 6/16/2025
|
|
Sinovac Biotech Ltd.
13D/A
Amendment 4
SVA · P8696W104
|
8.9% |
4/30/2025
Event 4/28/2025
|
|
Sinovac Biotech Ltd.
13D/A
Amendment 3
SVA · P8696W104
|
8.9% |
3/21/2025
Event 3/18/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.